Jiangsu Nanfang Medical Working Capital to Net Assets Ratio
Jiangsu Nanfang Medical working capital to net assets ratio. Jiangsu Nanfang Medical (603880) has a Working Capital to Net Assets ratio of -217.7% as of June 2026. Working capital of CN¥-355.88 Million (current assets of CN¥286.96 Million minus current liabilities of CN¥642.84 Million) is measured against net assets of CN¥163.51 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Jiangsu Nanfang Medical (603880) tangible net worth to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Jiangsu Nanfang Medical (2012–2025)
Working capital to net assets ratio of Jiangsu Nanfang Medical from 2012 to 2025. This chart shows how Jiangsu Nanfang Medical's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the ratio stands at -217.7%, reflecting working capital of CN¥-355.88 Million against net assets of CN¥163.51 Million CNY. See Jiangsu Nanfang Medical (603880) liquidity interval to measure how many days the company can operate on defensive assets alone.
Jiangsu Nanfang Medical Working Capital to Net Assets Ratio by Year (2012–2025)
Jiangsu Nanfang Medical working capital to net assets ratio by year from 2012 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Jiangsu Nanfang Medical from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Jiangsu Nanfang Medical.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -188.4% | CN¥-341.38 Million | CN¥181.17 Million | CN¥322.00 Million | CN¥663.38 Million | ▼ -68.9 pp |
| 2024 | -119.5% | CN¥-339.98 Million | CN¥284.41 Million | CN¥400.28 Million | CN¥740.26 Million | ▼ -72.6 pp |
| 2023 | -46.9% | CN¥-222.39 Million | CN¥474.22 Million | CN¥569.54 Million | CN¥791.92 Million | ▼ -26.1 pp |
| 2022 | -20.8% | CN¥-129.35 Million | CN¥621.48 Million | CN¥678.35 Million | CN¥807.70 Million | ▼ -24.1 pp |
| 2021 | 3.3% | CN¥21.43 Million | CN¥654.90 Million | CN¥587.89 Million | CN¥566.46 Million | ▼ -37.4 pp |
| 2020 | 40.6% | CN¥284.76 Million | CN¥700.80 Million | CN¥644.24 Million | CN¥359.47 Million | ▲ +3.8 pp |
| 2019 | 36.8% | CN¥208.99 Million | CN¥567.52 Million | CN¥501.45 Million | CN¥292.46 Million | ▼ -23.4 pp |
| 2018 | 60.2% | CN¥337.05 Million | CN¥560.04 Million | CN¥613.08 Million | CN¥276.03 Million | ▲ +2.1 pp |
| 2017 | 58.1% | CN¥312.07 Million | CN¥537.57 Million | CN¥587.38 Million | CN¥275.30 Million | ▲ +26.2 pp |
| 2016 | 31.9% | CN¥81.85 Million | CN¥256.69 Million | CN¥331.53 Million | CN¥249.67 Million | ▼ -4.9 pp |
| 2015 | 36.8% | CN¥81.90 Million | CN¥222.51 Million | CN¥332.04 Million | CN¥250.13 Million | ▼ -11.8 pp |
| 2014 | 48.6% | CN¥102.57 Million | CN¥210.90 Million | CN¥327.85 Million | CN¥225.28 Million | ▲ +11.4 pp |
| 2013 | 37.2% | CN¥62.72 Million | CN¥168.57 Million | CN¥266.63 Million | CN¥203.91 Million | ▲ +8.5 pp |
| 2012 | 28.7% | CN¥34.80 Million | CN¥121.38 Million | CN¥292.21 Million | CN¥257.41 Million | — |